ACLARION, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
ACLARION, INC. (ACON) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$193.32 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2023-08-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2023-08-25
- ACLARION, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-06-30 was -$1.02M.
- ACLARION, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-03-31 was $831.49K, a 382.61% increase year-over-year.
- ACLARION, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-06-30 was -$94.07K.
- ACLARION, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-03-31 was $172.29K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed |
|---|---|---|---|
| 2022-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-25 | -$193.32K 10-Q · filed 2023-08-25 | $119.07K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $831.49K 10-Q · filed 2022-06-06 | ||
| 2021-06-30 | -$94.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $78.22K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $172.29K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |